My cart
In the shopping cart is not goods, to choose and buy!
  • Product Name
  • Size
  • Quantity
  • Amount
    Selected items : 0 pieces Total : CHECK OUT()
    Catalog No: V0573
    CAS No. (CAS Registry Number): 152459-95-5
    Description: Imatinib (formerly STI-571, trade name Gleevec and Glivec) is an orally bioavailable multi-targeted kinase inhibitor with potential anticancer activity. It inhibits v-Abl, c-Kit and ...
    Catalog No: V0574
    CAS No. (CAS Registry Number): 146535-11-7
    Description: Tyrphostin AG 1296 (AG-1296) is a novel, potent, selective and ATP-competitive inhibitor of PDGFR with potential antitumor activity. It inhibits PDGFR with IC50 of 0.3-0.5 μM, it has no a...
    Catalog No: V0575
    CAS No. (CAS Registry Number): 917879-39-1
    Description: MK-2461 (MK2461) is a novel, potent, ATP-competitive, multi-targeted inhibitor for c-Met (WT/mutants) with potential antineoplastic activity. It inhibits various mutants of c-Met wit...
    Catalog No: V0576
    CAS No. (CAS Registry Number): 790299-79-5
    Description: Masitinib (formerly also known as AB1010)  is a novel, potent, orally bioavailable, selective and multi-targeted  inhibitor for Kit and PDGFRα/β with IC50 of 200 nM and 540 nM/8...
    Catalog No: V0577
    CAS No. (CAS Registry Number): 343787-29-1
    Description: CP-673451 (CP673451) is a novel, potent, selective and ATP-competitive inhibitor of PDGFR(α/β) with potential antitumor activity. It inhibits PDGFR(α/β) with IC50s of 10 nM/1 nM in cell-f...
    Catalog No: V0578
    CAS No. (CAS Registry Number): 128-57-4
    Description: Sennoside B is a naturally occuring anthraquinone glycoside compound isolated from Puffer fish, salamanders, frogs foot spot et al., It is a type of irritant laxative used to treat c...
    Products are for research use only;  We do not sell to patients
    Tel: 1-708-310-1919
    Fax: 1-708-557-7486
    Subscribe to our E-newsletter
    • Name*
    • *
    • E-mail*
    • *
    • instructions:
    • *
    Copyright 2020 InvivoChem LLC | All Rights Reserved